249 related articles for article (PubMed ID: 35871427)
21. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for critical illness and death among adult Brazilians with COVID-19.
Silva I; Faria NC; Ferreira ÁRS; Anastácio LR; Ferreira LG
Rev Soc Bras Med Trop; 2021; 54():e0014 2021. PubMed ID: 33950121
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcomes of hospitalized patients with COVID-19 in a city of South Brazil: Have they changed through the first year of the pandemic?
Demeneck H; Luiz Parmegiani de Oliveira A; do Carmo Machado Kneipp Lopes J; Ryoiti Matsunago L; Cavalca Grupenmacher L; Roberto Curcio Pereira M; Benício Stocco R; Ali El Chab Parolin S; Olandoski M; Pellegrino Baena C
PLoS One; 2023; 18(6):e0286589. PubMed ID: 37262056
[TBL] [Abstract][Full Text] [Related]
24. Profile of coronavirus disease enlightened asthma as a protective factor against death: An epidemiology study from Brazil during the pandemic.
Sansone NMS; Valencise FE; Bredariol RF; Peixoto AO; Marson FAL
Front Med (Lausanne); 2022; 9():953084. PubMed ID: 36523782
[TBL] [Abstract][Full Text] [Related]
25. Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.
Pontes GS; de Melo Silva J; Pinheiro-Silva R; Barbosa AN; Santos LC; de Pádua Quirino Ramalho A; de Castro Alves CE; da Silva DF; de Oliveira LC; da Costa AG; Bruno AC
Sci Rep; 2021 Sep; 11(1):17534. PubMed ID: 34475438
[TBL] [Abstract][Full Text] [Related]
26. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
27. Severe Acute Respiratory Syndrome (SARS) in the Context of the COVID-19 Pandemic Among Indigenous Peoples of Brazil: Epidemiology and Risk Factors Associated with Death.
Novaes TER; Lara DM; da Silva SG
J Racial Ethn Health Disparities; 2023 Jun; ():. PubMed ID: 37314690
[TBL] [Abstract][Full Text] [Related]
28. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 severe acute respiratory syndrome in Brazilian newborns in 2020-2021.
Pereira AR; Branco MDRFC; Costa SDSB; Lopes DAM; Pinheiro VV; Oliveira DC; Pasklan ANP; Gomes JA; Santos AMD; Gama MEA
Rev Bras Epidemiol; 2023; 26():e230012. PubMed ID: 36820749
[TBL] [Abstract][Full Text] [Related]
30. Human Development Index Is Associated with COVID-19 Case Fatality Rate in Brazil: An Ecological Study.
Palamim CVC; Boschiero MN; Valencise FE; Marson FAL
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564707
[TBL] [Abstract][Full Text] [Related]
31. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.
Saatci D; Ranger TA; Garriga C; Clift AK; Zaccardi F; Tan PS; Patone M; Coupland C; Harnden A; Griffin SJ; Khunti K; Dambha-Miller H; Hippisley-Cox J
JAMA Pediatr; 2021 Sep; 175(9):928-938. PubMed ID: 34152371
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak of the pandemic.
Barry M; Althabit N; Akkielah L; AlMohaya A; Alotaibi M; Alhasani S; Aldrees A; AlRajhi A; AlHiji A; Almajid F; AlSharidi A; Al-Shahrani FS; Alotaibi NH; AlHetheel A
Int J Infect Dis; 2021 May; 106():43-51. PubMed ID: 33771671
[TBL] [Abstract][Full Text] [Related]
33. First and second COVID-19 waves in Brazil: A cross-sectional study of patients' characteristics related to hospitalization and in-hospital mortality.
Zeiser FA; Donida B; da Costa CA; Ramos GO; Scherer JN; Barcellos NT; Alegretti AP; Ikeda MLR; Müller APWC; Bohn HC; Santos I; Boni L; Antunes RS; Righi RDR; Rigo SJ
Lancet Reg Health Am; 2022 Feb; 6():100107. PubMed ID: 34746913
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 pandemic evolution in the Brazilian Indigenous population.
Mendes MF; Pereira LR; Lima TM; Melani VF; Palamim CVC; Boschiero MN; Marson FAL
J Racial Ethn Health Disparities; 2022 Jun; 9(3):921-937. PubMed ID: 33782907
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry.
Pizzamiglio C; Pitceathly RDS; Lunn MP; Brady S; De Marchi F; Galan L; Heckmann JM; Horga A; Molnar MJ; Oliveira ASB; Pinto WBVR; Primiano G; Santos E; Schoser B; Servidei S; Sgobbi Souza PV; Venugopalan V; Hanna MG; Dimachkie MM; Machado PM;
Eur J Neurol; 2023 Feb; 30(2):399-412. PubMed ID: 36303290
[TBL] [Abstract][Full Text] [Related]
36. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
37. Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study.
Sousa BLA; Brentani A; Costa Ribeiro CC; Dolhnikoff M; Grisi SJFE; Ferrer APS; Ferraro AA
BMJ Open; 2021 Sep; 11(9):e050724. PubMed ID: 34489291
[TBL] [Abstract][Full Text] [Related]
38. The Digital Divide in Brazil and Barriers to Telehealth and Equal Digital Health Care: Analysis of Internet Access Using Publicly Available Data.
Nakayama LF; Binotti WW; Link Woite N; Fernandes CO; Alfonso PG; Celi LA; Regatieri CV
J Med Internet Res; 2023 Jul; 25():e42483. PubMed ID: 37477958
[TBL] [Abstract][Full Text] [Related]
39. Brazilian Black Women are at Higher Risk for COVID-19 Complications: An Analysis of REBRACO, a National Cohort.
Dantas-Silva A; Surita FG; Souza R; Rocha L; Guida JP; Pacagnella R; Tedesco R; Fernandes K; Martins-Costa S; Peret F; Feitosa F; Traina E; Cunha Filho E; Vettorazzi J; Haddad S; Andreucci C; Correa Junior M; Dias M; Oliveira L; Melo Junior E; Luz M; Cecatti JG; Costa ML
Rev Bras Ginecol Obstet; 2023 May; 45(5):253-260. PubMed ID: 37339644
[TBL] [Abstract][Full Text] [Related]
40. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
